State Street’s Bionano Genomics BNGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,851
Closed -$32K 4286
2024
Q4
$32K Sell
1,851
-49
-3% -$837 ﹤0.01% 4180
2024
Q3
$51.7K Hold
1,900
﹤0.01% 4092
2024
Q2
$77.3K Hold
1,900
﹤0.01% 4064
2024
Q1
$127K Hold
1,900
﹤0.01% 3983
2023
Q4
$215K Sell
1,900
-4,350
-70% -$454K ﹤0.01% 3883
2023
Q3
$1.14M Sell
6,250
-146
-2% -$38.3K ﹤0.01% 3496
2023
Q2
$2.34M Sell
6,396
-11,423
-64% -$5.16M ﹤0.01% 3340
2023
Q1
$11.9M Buy
17,819
+444
+3% +$394K ﹤0.01% 2557
2022
Q4
$15.2M Buy
17,375
+1,571
+10% +$1.98M ﹤0.01% 2440
2022
Q3
$17.4M Buy
15,804
+1,779
+13% +$2.35M ﹤0.01% 2326
2022
Q2
$11.6M Buy
14,025
+1,151
+9% +$1.18M ﹤0.01% 2623
2022
Q1
$19.9M Buy
12,874
+876
+7% +$1.18M ﹤0.01% 2409
2021
Q4
$21.5M Sell
11,998
-540
-4% -$1.44M ﹤0.01% 2430
2021
Q3
$41.4M Buy
12,538
+11
+0.1% +$38.5K ﹤0.01% 1948
2021
Q2
$55.1M Buy
12,527
+12,341
+6,635% +$48.7M ﹤0.01% 1768
2021
Q1
$904K Buy
+186
New +$1.05M ﹤0.01% 3646

Other funds holding BNGO

State Street's BNGO Position: Q1 2025 in Review

State Street sold out of Bionano Genomics (BNGO) in Q1 2025, closing a stake of 1,851 shares — an estimated $32K sold.

State Street first reported a position in BNGO in Q1 2021 and held it in 16 quarters. The position peaked at $55.1M in Q2 2021. 30 funds tracked by Wall St. Rank hold BNGO as of Q1 2025.

  • State Street reported no remaining Bionano Genomics position as of Q1 2025 after selling out during the quarter.
  • State Street sold 1,851 Bionano Genomics shares in Q1 2025, an estimated $32K.
  • State Street first reported a position in Bionano Genomics in Q1 2021 and held it in 16 quarters.
  • State Street's Bionano Genomics position peaked at $55.1M in Q2 2021.
  • 30 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2025.

Based on State Street's 13F filing for Q1 2025, filed 15 May 2025.